Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELANDD: Long-Term Nebivolol in Diastolic Heart Failure
2004-000746-20Phase 2Completed
- Sponsor
- Menarini Group
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) and left ventricular diastolic dysfunction (LVDD) comparing Nebivolol with Placebo (2 arms). Primary endpoint: 6-minute walk distance. Started May 2006; status: completed.
02
Drugs
nebivolol
03
Conditions
heart failure with preserved ejection fraction (HFpEF)left ventricular diastolic dysfunction (LVDD)
Beyond the preview
Go deeper on 2004-000746-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000746-20.